logo
  

Wolverine Worldwide Q4 Adj. Earnings Meet Estimates; Issues FY15 Outlook

Shoemaker Wolverine Worldwide Inc. (WWW) Tuesday reported fourth-quarter net earnings attributable to the company of $10.7 million or $0.10 per share, compared to net loss of $1.7 million or $0.02 per share in the comparable quarter last year.

Excluding certain items, earnings increased 36.4% to $0.30 per share from $0.22 per share last year. On average, 16 analysts polled by Thomson Reuters expected the company to earn $0.30 per share. Analysts' estimates typically exclude one-time items.

Revenues rose 9.2% to $808.9 million, from $740.8 million a year earlier, while 13 analysts had a consensus revenue estimate of $808.11 million for the quarter.

For fiscal 2015, the company expects earnings to be in the range of $1.46 to $1.53 per share, adjusted earnings in the range of $1.53 to $1.60 per share and annual revenue of $2.82 billion from the $2.87 billion. Analysts expect the company to report annual earnings of $1.65 on revenues of $2.88 billion.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
While reporting financial results for the first quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) raised its adjusted earnings and net sales growth guidance for the full-year 2024. For fiscal 2024, the company now projects earnings in a range of $1.43 to $1.48 per share and... Shares of Roche Holding AG were losing around 3 percent in Switzerland after the drug major reported weak sales in its first quarter and confirmed fiscal 2024 outlook. Excluding COVID-19-related products, quarterly sales increasedy 7 percent. For fiscal 2024, Roche continues to expect an increase in group sales in the mid single digit range at constant exchange rates. Dr. Reddy's Laboratories Ltd. is recalling six lots of Sapropterin Dihydrochloride Powder for Oral Solution 100 mg to the consumer level. According to the U.S. Food and Drug Administration, the recall was due to powder discoloration in some packets leading to decreased potency.

First quarter growth data from China gained the maximum focus this week as trends in the massive emerging economy impact its trading partners. Elsewhere, the IMF released its latest global macroeconomic projections. Read our story to find out why comments from the Fed Chair Powell damped rate cut expectations. Meanwhile, there was some survey data that kindled hopes of a recovery in manufacturing. In the U.K., inflation data for March revealed some confusing trends.

View More Videos
RELATED NEWS
Follow RTT